Beryl Drugs P/B Ratio

BERLDRG • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
1.2
Moderate Valuation
Moderate - Reasonably valued relative to book value

Current Valuation Metrics

P/B Ratio 1.2
Current Price ₹22.74
Book Value/Share ₹20.00
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹10 Cr
Share Capital ₹5 Cr
Reserves & Surplus ₹4 Cr
Outstanding Shares 5,000,000
Book Value per Share ₹20.00

Valuation Signal

Signal Fairly Valued
Historical Avg 1.25
Historical Range 0.76 - 2.01
Percentile 60.0%

Sector Context

Sector Average -0.1
Sector Median 0.66
Sector Rank #11 of 50
Sector Percentile 22.0%

Key P/B Ratio Insights for Beryl Drugs

  • Trading at premium to sector average PB of -0.1

View the current stock price of Beryl Drugs for more insights.

P/B Ratio Historical Trend for Beryl Drugs

Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.

Historical P/B Ratio Data

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 1.17 ₹20.0 ₹23.40 ₹10 Moderate
2024 2.01 ₹18.0 ₹36.15 ₹9 Moderate
2023 1.38 ₹16.0 ₹22.11 ₹8 Moderate
2022 0.93 ₹14.0 ₹13.00 ₹7 Low
2021 0.76 ₹16.0 ₹12.12 ₹8 Low

Sector P/B Ratio Comparison

Comparing Beryl Drugs with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.21
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -12.97 ₹4,391 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Triochem Products TRIPR 0.04 ₹0 Low
Murae Organisor MURAE 0.26 ₹55 Low